NCT06805942

Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (estimated)
• Sponsor: IR Centers · Academic / Other
• Sex: All
• Age: 22 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the feasibility and safety of using Lipiodol (ethiodized oil) as an investigational embolic agent for treating pain caused by plantar fasciitis. Participants will undergo a minimally invasive procedure called plantar fascia embolization (PFE) to reduce inflammation and pain in the affected area. The study aims to assess changes in pain levels, foot function, and any potential side effects over a six-month follow-up period.

Detailed description

This study investigates the use of Lipiodol (ethiodized oil) for plantar fascia embolization (PFE) to treat pain from plantar fasciitis. It focuses on evaluating safety, feasibility, and outcomes related to pain reduction and improved foot function.

Conditions

• Plantar Fasciitis of Both Feet

Interventions

Type	Name	Description
DEVICE	Lipiodol (ethiodized oil) injection	Lipiodol will be used as an embolic agent for arterial embolization targeting neovascularity in the plantar fascia to reduce inflammation and pain.

Timeline

• Start date: 2025-02-15
• Primary completion: 2025-09-30
• Completion: 2025-09-30
• First posted: 2025-02-03
• Last updated: 2025-02-03

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study